Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Platform for Extracellular Interactome Discovery Identifies Novel Functional Binding Partners for the Immune Receptors B7-H3/CD276 and PVR/CD155
Bushra Husain, Sree R. Ramani, Eugene Y. Chiang, et al.
Molecular & Cellular Proteomics (2019) Vol. 18, Iss. 11, pp. 2310-2323
Open Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

The cancer–natural killer cell immunity cycle
Nicholas D. Huntington, Joseph Cursons, Jai Rautela
Nature reviews. Cancer (2020) Vol. 20, Iss. 8, pp. 437-454
Closed Access | Times Cited: 448
Current Perspectives in Cancer Immunotherapy
Theodoulakis Christofi, Stavroula Baritaki, Luca Falzone, et al.
Cancers (2019) Vol. 11, Iss. 10, pp. 1472-1472
Open Access | Times Cited: 188
Immune checkpoint of B7-H3 in cancer: from immunology to clinical immunotherapy
Binghao Zhao, Huanzhang Li, Yu Xia, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 113
New frontiers in immune checkpoint B7-H3 (CD276) research and drug development
Ayechew Adera Getu, Abiye Tigabu, Ming Zhou, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 99
Endowing universal CAR T-cell with immune-evasive properties using TALEN-gene editing
Sumin Jo, Shipra Das, Alan F. Williams, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 96
A physical wiring diagram for the human immune system
Jarrod Shilts, Yannik Severin, Francis Galaway, et al.
Nature (2022) Vol. 608, Iss. 7922, pp. 397-404
Open Access | Times Cited: 94
Development of pharmacological immunoregulatory anti-cancer therapeutics: current mechanistic studies and clinical opportunities
Nanhao Yin, Xintong Li, Xuanwei Zhang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 20
New Emerging Targets in Cancer Immunotherapy: The Role of B7-H3
Ioannis‐Alexios Koumprentziotis, Charalampos Theocharopoulos, Dimitra Foteinou, et al.
Vaccines (2024) Vol. 12, Iss. 1, pp. 54-54
Open Access | Times Cited: 17
Tumor intrinsic and extrinsic immune functions of CD155
Jake S. O’Donnell, Jason Madore, Xian-Yang Li, et al.
Seminars in Cancer Biology (2019) Vol. 65, pp. 189-196
Closed Access | Times Cited: 114
B7-H3 Suppresses Antitumor Immunity via the CCL2–CCR2–M2 Macrophage Axis and Contributes to Ovarian Cancer Progression
Taito Miyamoto, Ryusuke Murakami, Junzo Hamanishi, et al.
Cancer Immunology Research (2021) Vol. 10, Iss. 1, pp. 56-69
Open Access | Times Cited: 99
The Immunoglobulin Superfamily Receptome Defines Cancer-Relevant Networks Associated with Clinical Outcome
Erik Verschueren, Bushra Husain, Kobe Yuen, et al.
Cell (2020) Vol. 182, Iss. 2, pp. 329-344.e19
Open Access | Times Cited: 87
The Role of CD276 in Cancers
Shengzhuo Liu, Jiayu Liang, Zhihong Liu, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 82
A Human IgSF Cell-Surface Interactome Reveals a Complex Network of Protein-Protein Interactions
Woj M. Wojtowicz, Jost Vielmetter, Ricardo A. Fernandes, et al.
Cell (2020) Vol. 182, Iss. 4, pp. 1027-1043.e17
Open Access | Times Cited: 79
Cellinker: a platform of ligand–receptor interactions for intercellular communication analysis
Yang Zhang, Tianyuan Liu, Jing Wang, et al.
Bioinformatics (2021) Vol. 37, Iss. 14, pp. 2025-2032
Open Access | Times Cited: 75
Homeostatic functions of monocytes and interstitial lung macrophages are regulated via collagen domain-binding receptor LAIR1
Shilpa Keerthivasan, Yasin Şenbabaoğlu, Nadia Martinez-Martín, et al.
Immunity (2021) Vol. 54, Iss. 7, pp. 1511-1526.e8
Open Access | Times Cited: 65
Light-mediated discovery of surfaceome nanoscale organization and intercellular receptor interaction networks
Maik Müller, Fabienne Gräbnitz, Niculò Barandun, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 59
Targeting the ubiquitination/deubiquitination process to regulate immune checkpoint pathways
Jiaxin Liu, Yicheng Cheng, Ming Zheng, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 58
DS-7300a, a DNA Topoisomerase I Inhibitor, DXd-Based Antibody–Drug Conjugate Targeting B7-H3, Exerts Potent Antitumor Activities in Preclinical Models
Michiko Yamato, Jun Hasegawa, Takanori Maejima, et al.
Molecular Cancer Therapeutics (2022) Vol. 21, Iss. 4, pp. 635-646
Open Access | Times Cited: 42
Tumors resurrect an embryonic vascular program to escape immunity
Elisabeth J. M. Huijbers, Kabir A. Khan, Robert S. Kerbel, et al.
Science Immunology (2022) Vol. 7, Iss. 67
Closed Access | Times Cited: 39
Inhibitory Receptors and Immune Checkpoints Regulating Natural Killer Cell Responses to Cancer
Irina Buckle, Camille Guillerey
Cancers (2021) Vol. 13, Iss. 17, pp. 4263-4263
Open Access | Times Cited: 55
Immunogenomics of Killer Cell Immunoglobulin-Like Receptor (KIR) and HLA Class I: Coevolution and Consequences for Human Health
Nicholas R. Pollock, Genelle F. Harrison, Paul J. Norman
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 7, pp. 1763-1775
Open Access | Times Cited: 30
B7-H3 in Brain Malignancies: Immunology and Immunotherapy
Xiaopeng Guo, Mengqi Chang, Yu Wang, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 12, pp. 3762-3780
Open Access | Times Cited: 20
Proteomics in the pharmaceutical and biotechnology industry: a look to the next decade
Jennie R. Lill, William R. Mathews, Christopher M. Rose, et al.
Expert Review of Proteomics (2021) Vol. 18, Iss. 7, pp. 503-526
Open Access | Times Cited: 36
A membrane protein display platform for receptor interactome discovery
Shengya Cao, Sean M. Peterson, Sören Müller, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 39
Open Access | Times Cited: 36
Blockade of the immunosuppressive KIR2DL5/PVR pathway elicits potent human NK cell–mediated antitumor immunity
Xiaoxin Ren, Mou Peng, Xing Peng, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 22
Open Access | Times Cited: 28
Page 1 - Next Page

Scroll to top